Canadian Cancer Society Pushes for Dedicated Cancer Care Funding in CHT Negotiations
Event summary
- Federal, provincial, and territorial Health Ministers meet in Winnipeg on October 15–16, 2026, to negotiate the Canada Health Transfer (CHT).
- Canadian Cancer Society (CCS) advocates for a 1% dedicated increase to the CHT, approximately $575 million annually, to strengthen cancer care.
- Cancer cases in Canada are projected to rise by 40% and cancer deaths by 44% between 2020 and 2040.
- CCS highlights the need for targeted CHT funding to save lives and reduce long-term healthcare costs.
The big picture
The Canadian Cancer Society's push for dedicated cancer care funding comes as cancer cases and deaths are projected to rise significantly. This advocacy aligns with a broader trend of increasing healthcare costs and the need for targeted funding to address specific health crises. The outcome of the CHT negotiations will have long-term implications for cancer care infrastructure and public health outcomes in Canada.
What we're watching
- Funding Allocation
- How the 1% dedicated increase to the CHT will be allocated and whether it will be sufficient to address the rising cancer burden.
- Policy Implementation
- The pace at which targeted cancer care funding will be implemented across provinces and territories.
- Equitable Access
- Whether the proposed funding will ensure equitable access to cancer care across Canada.
